Novel neuroprotectant loberamisal boosts functional recovery after stroke
19 Feb 2026
bởiElaine Soliven
In patients with acute ischaemic stroke, administration of loberamisal, a novel neuroprotective agent, within 48 hours of symptom onset improves functional outcomes, according to the LAIS* trial presented at ISC 2026.